Bauke Anninga was a principal at M Ventures for two years.

Anninga promoted at M Ventures

Bauke Anninga has announced his promotion at M Ventures, the corporate venture capital firm of Germany-based science and technology company Merck Group.

After serving two years as the principal of M Ventures, Anninga will now act as the firm’s investment director.

He began at M Ventures in 2019 as an associate, a position he held for two years. During this time he was board director and board observer at several startups such as Rewind Therapeutics and Immunitas Therapeutics.

Before joining M Ventures, Anninga spent a year as a healthcare investment banker at Jefferies, a global investment banking company, and was the director of new ventures for a year at Cambridge Squared, a boutique life science investment company.

Founded in 2009, M Ventures invests in healthcare, IT and life sciences startups. The unit has 68 companies in its portfolio and has invested in 159 startups including Neologic, Astraveus and Nouscom.

Roshini Bains

Roshini Bains is the junior news reporter for Global Corporate Venturing and Global University Venturing.